MAPT and Alzheimer disease: As AD progresses, propelled by the damaging bidirectional pathway between tau and Aβ, changes occur to the composition of the proteasome, including significant upregulation of immunoproteasome subunits (Orre et al., 2013), and normal proteasomal degradation pathways are altered.